Open-house rebate agreement for Chlortalidon
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04
Opportunity Score
Why this score?
Opportunity
58 / 100
Complexity
42 / 100
Risk factors
For paper submissions, advance fax/scan/email/portal transmission is only timely if the original paper documents arrive...
Eligibility is limited to pharmaceutical companies and requires a signed declaration of reliability.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Nov 2026
- Non-exclusive rebate agreements for pharmaceutical products containing Chlortalidon (ATC C03BA04).
- Open-house model with identical, pre-set contract terms for all eligible pharmaceutical companies.
Show full summary
Open-house supply arrangement for pharmaceutical products: AOK Bayern seeks non-exclusive rebate agreements for the active substance Chlortalidon (ATC C03BA04). The model is explicitly described as open-house, with no selection among bidders and identical non-negotiable contract terms for all eligible pharmaceutical companies. The notice provides clear submission routes and a monthly accession mechanism, but no contract value is stated.
Risks
For paper submissions, advance fax/scan/email/portal transmission is only timely if the original paper documents arrive...
Eligibility is limited to pharmaceutical companies and requires a signed declaration of reliability.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies are eligible as potential contract partners.
Administrative
- Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
- Submission of the signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open-house rebate agreement for Chlortalidon
Single lot for non-exclusive pharmaceutical rebate agreements covering Chlortalidon (ATC C03BA04). Scope is supplies of pharmaceutical products under an open-house model; contract terms are identical and not individually negotiable. Performance is in Germany, specifically Bavaria (DE212).
Location
Duration
Category
Deadline
Award details
Siehe kurze Beschreibung
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04
Original TED description
Siehe kurze Beschreibung
Procurement Details
- Publication date
- 16 Oct 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 628089-2024
Documents (2)
Similar tenders
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
58 / 100
Complexity
42 / 100
Risk factors
For paper submissions, advance fax/scan/email/portal transmission is only timely if the original paper documents arrive...
Eligibility is limited to pharmaceutical companies and requires a signed declaration of reliability.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications